AGM/EGMJun 11, 2026, 04:22 PM
Zomedica Shareholders Elect Directors, Ratify Auditor, Approve By-Law Change; Reject Executive Pay
AI Summary
Zomedica Corp. held its Annual Meeting of Shareholders on June 10, 2026, where shareholders elected all eight director nominees and ratified the appointment of Grant Thornton LLP as its independent auditor. An amendment to the company's By-Laws concerning quorum requirements for adjourned meetings was also approved. However, shareholders did not approve, on an advisory basis, the compensation of the company's named executive officers.
Key Highlights
- Zomedica Corp. shareholders elected all eight director nominees at the Annual Meeting.
- The appointment of Grant Thornton LLP as the independent registered public accounting firm for 2026 was ratified.
- Shareholders approved an amendment to the By-Laws regarding quorum requirements for adjourned meetings.
- A non-binding advisory vote to approve the compensation of named executive officers failed.
- Proposal 1 (Director Election) received 148,970,700 'For' votes for Jeffrey Rowe.
- Proposal 2 (Auditor Ratification) received 403,285,558 'For' votes.
- Proposal 3 (Executive Compensation) received 99,891,977 'For' votes against 129,290,109 'Against' votes.
- Proposal 4 (By-Laws Amendment) received 123,410,315 'For' votes.
Price Impact
More from ZOMDF